Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).

Delgado, Maria Gabriela; Mertineit, Nando; Bosch, Jaime; Baumgartner, Iris; Berzigotti, Annalisa (2024). Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS). (In Press). Digestive and liver disease Elsevier 10.1016/j.dld.2024.03.003

[img] Text
1-s2.0-S1590865824003037-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (992kB) | Request a copy

UNLABELLED

TIPS is the most effective treatment for portal hypertension. Patient selection remains important to achieving optimal post-TIPS outcomes. The study evaluates 1-year mortality factors in cirrhotic patients receiving TIPS.

METHODS

87 cirrhotic patients received a TIPS between 2015 - 2021. Predictors of 1-year and overall mortality were assessed by estimating cumulative incidence functions and Grey's test to adjust for liver transplantation as a risk competing with mortality. Variables with p < 0.05 were checked for collinearity and included in the multivariate Cox proportional hazards model. Model discrimination was evaluated by calculating the area under the ROC curve.

RESULTS

87 patients were included (68% men; 22% ≥70 years). ALD was the primary cirrhosis cause. Most patients were Child-Pugh class B, MELD-Na score was 13.6 ± 6.0 points. The most frequent indication for TIPS was bleeding (51.7%), followed by refractory ascites (42.5%). The variables positively associated with mortality in univariate analysis were ascites, clinically overt sarcopenia and MELD-Na score, while ongoing nutritional supplementation improved survival. In the multivariate analysis, only clinically overt sarcopenia and MELD-Na score remained independently associated with mortality. A MELD-Na/sarcopenia model demonstrated a good discrimination, AUROC: 0.86 (95% CI 0.77 - 0.95).

CONCLUSION

MELD-Na score, and sarcopenia were significantly associated with 1-year survival in cirrhotic patients who received TIPS.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Delgado, Maria Gabriela, Mertineit, Nando, Bosch Genover, Jaime, Berzigotti, Annalisa

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1590-8658

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

02 Apr 2024 10:31

Last Modified:

03 Apr 2024 04:06

Publisher DOI:

10.1016/j.dld.2024.03.003

PubMed ID:

38555198

Uncontrolled Keywords:

Cirrhosis MELD-Na score Mortality Sarcopenia Transjugular intrahepatic portosystemic shunt (TIPS)

BORIS DOI:

10.48350/195438

URI:

https://boris.unibe.ch/id/eprint/195438

Actions (login required)

Edit item Edit item
Provide Feedback